Transfusion requirements from time of presentation to the end of the trial period (48 hours) for patients randomised to receive injection sclerotherapy or octreotide
| Injection sclerotherapy (n=77) | Octreotide (n=73) | |
| Blood (units) | ||
| Mean (SD) | 7.5 (5.2) | 6.9 (4.4) |
| Median (range) | 13 (6–19) | 10 (2–20) |
| Colloid (units) | ||
| Mean (SD) | 5.2 (5.6) | 4.9 (4.2) |
| Median (range) | 6 (1–4) | 6 (1–11) |